# Trial of Olaparib in Combination With AZD5363 (ComPAKT)

> **NCT02338622** · PHASE1 · COMPLETED · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 60 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** olaparib
- **DRUG:** AZD5363

## Key facts

- **NCT ID:** NCT02338622
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-31
- **Primary completion:** 2016-03-21
- **Final completion:** 2017-03-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338622, "Trial of Olaparib in Combination With AZD5363 (ComPAKT)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02338622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*